Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations - a podcast by Clinical Care Options

In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses therapeutic options for younger, fit patients with AML and no targetable mutations. Topics include:

• Induction chemotherapy and consolidation therapy
• Use of gemtuzumab ozogamicin
• Management of sinusoidal obstruction syndrome  
• Nursing considerations for younger, fit patients with AML

Presenter:

Ashley Leak Bryant, PhD, RN, OCN, FAAN
Associate Professor
School of Nursing
UNC Lineberger Comprehensive Cancer Center  
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

 

Further episodes of CCO Oncology Podcast

Further podcasts by Clinical Care Options

Website of Clinical Care Options